FDA Press Office Shakeup Startles Ousted Staffers
This article was originally published in The Tan Sheet
A young FDA official's decision to boot three seasoned press specialists from the Public Affairs Office may be an embarrassment for the agency.
You may also be interested in...
Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus
Pink Sheet reporter and editors examine the struggle over the FDA’s reputation, whether a coronavirus vaccine could be made available without sponsor cooperation, and the late Supreme Court Justice Ruth Bader Ginsburg’s legacy for pharma.
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.